切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 93 -96. doi: 10.3877/cma.j.issn.1674-3253.2021.02.002

所属专题: 文献

临床研究

DDD评分系统在肾癌后腹腔镜肾部分切除术中的临床应用价值
章民昊1, 顾鹏1,(), 何晓亮1, 王彬1   
  1. 1. 214000 江苏,无锡市锡山人民医院泌尿外科
  • 收稿日期:2020-04-20 出版日期:2021-04-01
  • 通信作者: 顾鹏

Clinical application value of DDD scoring system in retroperitoneoscopic partial nephrectomy for renal cell carcinoma

Minhao Zhang1, Peng Gu1,(), Xiaoliang He1, Bin Wang1   

  1. 1. Department of Urology, Xishan people's Hospital of Wuxi, Wuxi, 214105, China
  • Received:2020-04-20 Published:2021-04-01
  • Corresponding author: Peng Gu
引用本文:

章民昊, 顾鹏, 何晓亮, 王彬. DDD评分系统在肾癌后腹腔镜肾部分切除术中的临床应用价值[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 93-96.

Minhao Zhang, Peng Gu, Xiaoliang He, Bin Wang. Clinical application value of DDD scoring system in retroperitoneoscopic partial nephrectomy for renal cell carcinoma[J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(02): 93-96.

目的

探讨DDD评分系统在肾癌患者行后腹腔镜肾部分切除术中,对预估肿瘤复杂性、手术难度及并发症发生风险的实际应用价值。

方法

收集2015年1月至2019年10月我科住院的行后腹腔镜肾部分切除术的51例肾癌患者的临床资料。根据DDD评分系统分为低度复杂组、中度复杂组、高度复杂组,并收集比较各组患者的年龄、性别、肿瘤位置、体质量指数(BMI)、手术时间、术中热缺血时间、术中出血量、手术前后血肌酐差值、术后住院天数及并发症情况。

结果

51例患者中,低度复杂组21例、中度复杂组15例、高度复杂组15例。三组患者年龄、性别、肿瘤位置及BMI差异无统计学意义(P>0.05)。平均手术时间分别为(74.6±13.1) min、(88.0±31.5) min、(111.0±25.0)min,平均术中热缺血时间分别为(10.4±1.8)min、(13.0±2.9)min、(20.6±5.6)min,平均术中出血量分别为(47±27)ml、(56±27) ml、(68±20) ml,复杂程度越高,术中出血量越多,热缺血时间越长,手术时间越长(P<0.05)。各组平均术后血肌酐增加值分别为(4.8±6.7) μmol/L、(10.2±4.9)μmol/L、(10.6±5.3) μmol/L,平均术后住院天数分别为(6.7±0.9)d、(10.4±5.6)d、(10.4±2.1) d,低度复杂组与其他两组比较,术后血肌酐变化小,术后住院时间短,差异有统计学意义(P<0.05)。另外,高度复杂组的术后并发症发生风险是低度复杂组的3.65倍(P<0.05),并且DDD评分系统预测术后并发症发生的精度较高(AUC=0.894)。

结论

DDD评分系统在肾癌后腹腔镜肾部分切除术中,对预估肿瘤复杂性、手术难度及术后并发症发生风险有较好的临床应用价值。

Objective

To investigate the value of DDD scoring system in retroperitoneoscopic partial nephrectomy for patients with renal cell carcinoma to estimate the tumor complexity, surgical difficulty and risk of complications.

Methods

The clinical data of 51 patients with renal cell carcinoma who underwent retroperitoneoscopic partial nephrectomy from January 2015 to October 2019 were collected. The patients were divided into low-grade complex group, moderate-complex group and high-complex group according to DDD scoring system. The age, gender, tumor location, body mass index (BMI), operation time, intraoperative warm ischemia time, intraoperative blood loss, preoperative and postoperative serum creatinine difference, postoperative hospital stay and complications were collected and compared among the three groups.

Results

Of the 51 patients, 21 cases were in the low-grade complex group, 15 cases were in the moderate-complex group, and 15 cases were in the high-grade complex group. There was no statistically significant difference in age, gender, tumor location and BMI among the three groups (P>0.05). The average operation time was (74.6±13.1) min, (88.0±31.5) min and (111.0 ±25.0) min, the average intraoperative warm ischemia time was (10.4±1.8) min, (13.0±2.9) min and (20.6 ± 5.6) min, and the average intraoperative blood loss was (47.1±27.2) ml, (56.0±26.7) ml and (68.0±20.1) ml, respectively. The higher the DDD score, the blood loss was more, the warm ischemia time was longer, and the operation time was longer (P<0.05). The mean postoperative increase of serum creatinine in each group was (4.8±6.7) μmol/L, (10.2 ±4.9) μmol/L and (10.6±5.3) μmol/L, respectively, and the mean postoperative hospital stay was (6.7±0.9) d, (10.4 ±5.6) d and (10.4±2.1) d, respectively. Compared with the other two groups, the postoperative change of serum creatinine was small and the postoperative hospital stay was short, and the differences had statistical significance (P<0.05). In addition, the risk of postoperative complications was 3.65 times higher in the highly complex group than in the low-complex group (P<0.05), and the DDD scoring system had a higher accuracy in predicting the occurrence of postoperative complications (AUC=0.894).

Conclusion

DDD scoring system in retroperitoneoscopic partial nephrectomy for renal cell carcinoma has a good clinical value in predicting the complexity of the tumor, the difficulty of surgery and the risk of postoperative complications.

图1 DDD肾脏肿瘤评分系统
表1 各组肾部分切除患者的一般临床资料比较
表2 各组肾部分切除患者围手术期有关数据比较(±s
表3 各组肾部分切除患者并发症情况
[1]
徐楚潇,刘茁,马潞林. 肾癌放疗的研究进展[J]. 中华泌尿外科杂志, 2019, 40(11): 873-876.
[2]
董毅,王林辉. 转移性肾癌减瘤性肾切除术的指征该如何把握[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(5): 289-292.
[3]
王苏贵,阳东荣,单玉喜, 等. R.E.N.A.L.评分系统在后腹腔镜肾部分切除术中的应用[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2016, 10(2): 18-21.
[4]
王林辉,时佳子. 肾癌肾部分切除术的指征应该怎么把握[J]. 中华泌尿外科杂志, 2018, 39(6): 403-406.
[5]
Jonasch E. Updates to the management of kidney cancer[J]. J Natl Compr Canc Netw, 2018, 16(5S): 639-641.
[6]
董毅,王正,王辉, 等. 肾部分切除术与根治性肾切除术治疗老年cT1~2期肾肿瘤围手术期指标及肾功能随访分析[J]. 中华泌尿外科杂志, 2019, 40(5): 351-355.
[7]
晁流,刘宁,甘卫东, 等. 保留肾单位术与根治性肾切除术对肾功能影响的比较[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2017, 11(6): 393-397.
[8]
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth[J]. J Urol, 2009, 182(3): 844-853.
[9]
Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery[J]. Eur Urol, 2009, 56(5): 786-793.
[10]
Simmons MN, Ching CB, Samplaski MK, et al. Kidney tumor location measurement using the C index method[J]. J Urol, 2010, 183(5): 1708-1713.
[11]
Zhang ZY, Pan X, Fan Y, et al. DDD score for renal tumor: An intuitive and comprehensive anatomical scoring system to access the outcomes of retroperitoneal laparoscopic partial nephrectomy[J]. Int J Urol, 2019, 26(4): 451-456.
[12]
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience[J]. Ann Surg, 2009, 250(2): 187-196.
[13]
谢福晨,张会江,张伟丽, 等. 新一代肾肿瘤评分系统的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(2): 140-144.
[14]
杨浩森,阴克强,双卫兵. 肾肿瘤评分系统的研究进展[J]. 现代泌尿生殖肿瘤杂志, 2019, 11(4): 252-256.
[15]
张中元,朱军,虞巍, 等. DDD肾肿瘤评分系统应用于肾肿瘤手术决策的临床分析[J]. 中华临床医师杂志(电子版), 2019, 13(2): 99-104.
[1] 董湘如, 初银珠, 黎富新, 张锋, 张玉莹, 吴长君. 超声造影与多层增强螺旋CT对肾占位性病变诊断价值的对比研究[J]. 中华医学超声杂志(电子版), 2022, 19(11): 1238-1243.
[2] 赵佳晖, 王永兴, 彭涛, 李明川, 魏德超, 韩毅力, 侯铸, 姜永光, 罗勇. 后腹腔镜根治性肾切除手术时间延长和术中出血量增多的影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 575-580.
[3] 刘阳阳, 王梁, 戴志红, 郝建戈, 张力仁, 刘志宇. 腹膜后去分化脂肪肉瘤合并左肾透明细胞癌一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 412-414.
[4] 杨春亭, 毛云华, 罗云, 刘博皓. 孤立肾合并肾混合性上皮间质肿瘤一例报告并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 407-409.
[5] 李国良, 吴凡, 李浩民, 江俊斌, 郭泽雄, 卓育敏, 马鑫, 赖彩永. 抽栓技术在完全腹腔镜左肾癌合并Ⅳ级腔静脉癌栓取出术的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 403-406.
[6] 董翔, 马文亮, 纪长威, 李笑弓, 张古田, 甘卫东, 郭宏骞. 回顾性评估肾细胞癌假包膜状态及其影响因素[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 356-360.
[7] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[8] 陈伟, 周骏, 梁朝朝. 机器人辅助腹腔镜下右肾部分切除术治疗后肾腺瘤一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 293-293,298.
[9] 唐国军, 洪余德, 赵崇玉, 李辽源. 基于TCGA数据库Wnt相关长链非编码RNA构建肾乳头状细胞癌预后模型[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 270-275.
[10] 卓然, 朱逸琪, 逯艳文, 马文亮, 郭宏骞, 甘卫东. 性别对Xp11.2易位型肾癌及肾透明细胞癌临床特征的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 105-109.
[11] 周硕明, 甘卫东. 2022版欧洲泌尿外科学会肾细胞癌诊疗指南更新要点解读[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 100-104.
[12] 刘宇明, 钟文文, 瞿虎, 王德娟, 邱剑光. 吸引器吹气法在层面外科腹腔镜肾部分切除术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 50-53.
[13] 陈世凯, 牟君一, 宋诗璋, 申宵茹, 侯四川. 肾肿瘤评分系统的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(06): 574-578.
[14] 朱嘉宁, 赵萍, 李楠, 朱连华, 李静波, 罗渝昆, 李秋洋. 术前及术中超声在最大径≤1.5 cm小肾肿瘤中的临床应用研究[J]. 中华肾病研究电子杂志, 2023, 12(01): 20-25.
[15] 王苏贵, 乔艳, 皇立媛, 吴自余, 张先云, 姜福金, 李强. 肾肿瘤侵入指数在肾癌后腹腔镜肾部分切除术中的临床应用[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1229-1233.
阅读次数
全文


摘要